Whetstone reports 5.3% stake in Health Catalyst
Health Catalyst, Inc. received an updated ownership report showing that Whetstone Capital Advisors, LLC and David Atterbury together beneficially own 3,750,377 shares of its common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Health Catalyst, Inc. received an updated ownership report showing that Whetstone Capital Advisors, LLC and David Atterbury together beneficially own 3,750,377 shares of its common stock. This stake represents 5.3% of the company’s outstanding common shares as of the reporting date.
The filing states that the reporting persons share both voting and dispositive power over all of these shares and have no sole voting or dispositive authority. They also certify that the shares were not acquired for the purpose of changing or influencing control of Health Catalyst.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in HCAT does Whetstone Capital report?
Who are the reporting persons in this Health Catalyst (HCAT) Schedule 13G/A?
What class of Health Catalyst (HCAT) securities is covered in this filing?
Is Whetstone’s HCAT position reported as passive or control-seeking?
What is the relevant date for this HCAT Schedule 13G/A ownership report?
AI-generated analysis. How Rhea-AI works. Not financial advice.